EngineeringMatterattheAtomicScale
Nexus Nano Labs pioneers breakthroughs in nanotechnology, advanced materials and molecular engineering.
Scientific
Foundations
Four convergent technology pillars that constitute the operating core of our research and commercial pipeline.
Nanomaterials
Engineered materials with molecular-scale precision. We design and synthesize nanostructures with extraordinary strength-to-weight ratios, thermal resistance, and conductivity profiles impossible in bulk materials.
Molecular Engineering
Atom-by-atom construction of complex functional molecules. Our synthesis platforms achieve structural complexity that conventional chemistry cannot approach, enabling programmable molecular machines.
Nano Robotics
Autonomous nanoscale agents designed to navigate biological and material environments. Programmable, self-replicating molecular robots for targeted delivery, repair, and assembly tasks.
Quantum Surfaces
Atomically flat substrates and quantum-confined surface states enable unprecedented electron transport characteristics. The basis of next-generation computing, sensing, and energy conversion.
Six Years of
Breakthroughs
Laboratory Foundation
Nexus Nano Labs established in Cambridge. Secured Series A funding of $42M. First electron microscopy suite operational.
First Synthesis Breakthrough
Successful synthesis of a novel carbon nanotube architecture with 3× the tensile strength of previously known variants.
FDA Fast-Track Designation
Nano-encapsulated drug delivery platform received FDA Fast-Track designation for targeted oncology applications.
Quantum-Nano Interface
World-first demonstration of a quantum-dot nano transistor operating at room temperature. Published in Nature Nanotechnology.
Industrial Scale
Proprietary roll-to-roll nano-deposition process achieves industrial output with sub-5nm uniformity across 2m substrate widths.
Global Research Network
Partnerships formalized with 14 institutions across 9 countries. Joint research programmes with MIT, ETH Zürich, and KAUST.
Applied
Science
Nanotechnology's impact extends across every critical industry. Our platform technologies enable transformational applications.
Medicine
Nano-carriers that navigate the bloodstream to deliver therapeutics directly to tumour cells, bypassing healthy tissue entirely. Nano-diagnostic sensors detect pathology at the single-molecule level.
Energy
Nanostructured electrode materials deliver energy densities 4× above commercial lithium-ion. Nano-textured photovoltaic surfaces increase solar absorption by 40%.
Computing
Post-silicon computing built on molecular switch arrays operating at 1.2nm feature sizes — 18 generations beyond current CMOS roadmaps.
Aerospace
Carbon nano-reinforced composites and nano-ceramic thermal coatings for hypersonic vehicles. Strength of titanium at 30% the mass.
Where Theory
Meets Precision
Our 18,000 sq ft research campus houses the most advanced nanoscale fabrication and characterisation tools in private research. Four transmission electron microscopes, three UHV surface science chambers, and a dedicated cleanroom complex form the backbone of our capabilities.
Every experiment is conducted under ultra-high-vacuum conditions with precision temperature control. Our cryo-TEM operates at −196°C, enabling atomic-resolution imaging of biological nanostructures in their native state.
Measurable
Excellence
Scientific
Validation
Peer review and institutional partnerships confirm the integrity and impact of our research.
"Nexus has fundamentally changed what our lab believes is achievable at the nanoscale. Their synthesis protocols are 18 months ahead of anything we have seen in published literature."
Prof. A. Reinholt
Chair of Nanoscience, ETH Zürich
"The quantum-nano interface demonstrated by Nexus is the most significant computing materials breakthrough this decade. We are proud to be their research partner."
Dr. S. Nakamura
Senior Researcher, MIT CSAIL
"Our oncology trials using Nexus nano-carriers show an efficacy improvement that no conventional drug formulation has achieved. The data is extraordinary."
Dr. C. Vasquez, MD
Principal Investigator, UCSF Cancer Center
Begin the
Dialogue
Whether you represent an institution, industry partner, or investor, we welcome precision-focused collaboration. All enquiries are reviewed by our research leadership.